Eli Lilly
LLY
#13
Rank
NZ$1.526 T
Marketcap
NZ$1,703
Share price
-1.54%
Change (1 day)
24.90%
Change (1 year)

With over 33,000 employees worldwide, production plants in 13 countries and annual sales of over $22 billion worldwide, Eli Lilly and Company is one of the largest pharmaceutical companies in the world. It was founded in Indianapolis in 1876 by the pharmacologist, officer and entrepreneur Eli Lilly.

Market capitalization of Eli Lilly (LLY)

Market cap: NZ$1.526 Trillion

As of December 2025 Eli Lilly has a market cap of NZ$1.526 Trillion. This makes Eli Lilly the world's 13th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Eli Lilly from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$1.526 T22.24%
2024NZ$1.248 T42.72%
2023NZ$875.03 B59.82%
2022NZ$547.50 B41.53%
2021NZ$386.84 B72.82%
2020NZ$223.83 B19.79%
2019NZ$186.86 B2.41%
2018NZ$182.46 B39.34%
2017NZ$130.94 B11.71%
2016NZ$117.21 B-13.86%
2015NZ$136.07 B39.14%
2014NZ$97.79 B41.09%
2013NZ$69.31 B0.84%
2012NZ$68.73 B11.49%
2011NZ$61.65 B17.8%
2010NZ$52.33 B-7.36%
2009NZ$56.49 B-28.4%
2008NZ$78.89 B-0.21%
2007NZ$79.06 B-5.53%
2006NZ$83.69 B-10.56%
2005NZ$93.56 B3.94%
2004NZ$90.02 B-25.95%
2003NZ$121.57 B-10.73%
2002NZ$136.19 B-35.9%
2001NZ$212.46 B-10.19%
2000NZ$236.58 B70.53%
1999NZ$138.73 B-24.97%
1998NZ$184.90 B38.77%
1997NZ$133.24 B131.67%
1996NZ$57.51 B

End of Day market cap according to different sources

On Dec 9th, 2025 the market cap of Eli Lilly was reported to be:

NZ$1.609 Trillion
by Nasdaq info icon info icon
NZ$1.526 Trillion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Bristol-Myers Squibb
BMY
NZ$178.76 B-88.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$419.57 B-72.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$835.23 B-45.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$249.68 B-83.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$202.40 B-86.74%๐Ÿ‡ซ๐Ÿ‡ท France
GlaxoSmithKline
GSK
NZ$166.00 B-89.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
AbbVie
ABBV
NZ$683.26 B-55.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$292.99 B-80.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$435.81 B-71.45%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AstraZeneca
AZN
NZ$482.82 B-68.37%๐Ÿ‡ฌ๐Ÿ‡ง UK